Guo Meng
Director/Board Member at SSY GROUP LIMITED
Net worth: 13 M $ as of 2024-03-30
Profile
Guo Meng is currently an Executive Director & Deputy General Manager at SSY Group Ltd., a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd., and a Director at Hebei Guolong Pharmaceutical Co., Ltd.
Previously, Mr. Meng served as the Executive President & Director at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Mr. Meng's education includes an undergraduate degree from Lanzhou University and a graduate degree from Beijing University of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SSY GROUP LIMITED
0.67% | 2023-06-29 | 20,000,000 ( 0.67% ) | 13 M $ | 2024-03-30 |
Guo Meng active positions
| Companies | Position | Start |
|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 2021-08-26 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | - |
| Hebei Guolong Pharmaceutical Co., Ltd. | Director/Board Member | - |
Former positions of Guo Meng
| Companies | Position | End |
|---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | President | - |
Training of Guo Meng
| Lanzhou University | Undergraduate Degree |
| Beijing University of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Hebei Guolong Pharmaceutical Co., Ltd. |
- Stock Market
- Insiders
- Guo Meng
